Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 08-2015 | 08-2014 | 08-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95,443 | N/A | 8,095 | 3,423 | 8,881 |
| Marketable Securities | N/A | N/A | N/A | 24,579 | 21,630 |
| Receivables | N/A | N/A | 577 | 370 | 957 |
| Inventories | N/A | N/A | N/A | 84 | 20 |
| Other current assets | 0 | 0 | 617 | 240 | 157 |
| TOTAL | $96,159 | $N/A | $9,766 | $29,329 | $32,436 |
| Non-Current Assets | |||||
| PPE Net | 91 | N/A | 1,258 | 2,996 | 4,633 |
| Other Non-Current Assets | 11,412 | 0 | 98 | 99 | 109 |
| TOTAL | $11,503 | $N/A | $1,356 | $3,095 | $4,742 |
| Total Assets | $107,662 | $N/A | $11,122 | $32,424 | $37,178 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 802 | 426 | 154 |
| Accounts payable and accrued liabilities | 1,252 | 0 | 4,402 | 4,278 | 3,825 |
| Accrued Expenses | 1,337 | N/A | N/A | N/A | N/A |
| Other current liabilities | N/A | N/A | 18 | 18 | 18 |
| TOTAL | $2,589 | $N/A | $5,222 | $4,722 | $3,997 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 18 | 82 |
| Other Non-Current Liabilities | 5,380 | 0 | 1,687 | 75 | 93 |
| TOTAL | $5,380 | $N/A | $1,687 | $93 | $175 |
| Total Liabilities | $7,969 | $N/A | $6,909 | $4,815 | $4,172 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 8,831 | 6,033 | 3,153 |
| Common Shares | N/A | N/A | 88 | 60 | 248 |
| Retained earnings | -115,909 | N/A | -332,061 | -303,905 | -274,584 |
| Other shareholders' equity | 0 | 0 | 762 | -595 | -696 |
| TOTAL | $99,693 | $N/A | $4,213 | $27,609 | $33,006 |
| Total Liabilities And Equity | $107,662 | $0 | $11,122 | $32,424 | $37,178 |